Donald M. Soffer - May 17, 2022 Form 4 Insider Report for Longeveron Inc. (LGVN)

Role
Director
Signature
/s/ Paul T. Lehr, attorney-in-fact
Stock symbol
LGVN
Transactions as of
May 17, 2022
Transactions value $
$0
Form type
4
Date filed
5/19/2022, 06:00 PM
Previous filing
Apr 18, 2022
Next filing
Dec 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGVN Common Stock Other $0 -7.02M -100% $0.00* 0 May 17, 2022 Held by affiliate entity F1, F2
transaction LGVN Common Stock Other $0 +6.54M +4122.8% $0.00 6.69M May 17, 2022 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.
F2 Shares distributed on pro rated basis to members of DS Med, LLC, for no consideration.
F3 Shares received as part of pro rata distribution by DS Med, LLC, to its members for no consideration.
F4 Amount includes 6,535,223 shares of Class B Common Stock.